Cryo-Cell International, Inc. (CCEL)
NYSE American - Nasdaq Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Show:
Annual
Cash flow
All numbers in thousandsBreakdown
ttm
30/11/2023
30/11/2022
30/11/2021
30/11/2020
30/11/2019
Cash flows from operating activities
Net income
-9,732
-9,522
2,771
2,084
3,625
-
Depreciation & amortisation
1,422
1,710
1,809
1,326
635.975
-
Deferred income taxes
-
-6,750
-1,732
-1,646
-1,284
-
Stock-based compensation
810.82
816.639
461.345
301.616
622.12
-
Change in working capital
4,461
5,985
4,250
4,857
3,756
-
Accounts receivable
-1,343
-1,569
-1,720
532.788
-828.594
-
Inventory
179.842
360.445
490.002
210.277
454.943
-
Accounts payable
-463.821
688.935
115.527
532.384
-411.721
-
Other working capital
-802.127
1,281
-8,596
974.923
8,017
-
Other non-cash items
-869.918
-1,029
451.167
-725.63
-784.243
-
Net cash provided by operating activities
6,919
8,920
8,573
7,926
8,467
-
Cash flows from investing activities
Investments in property, plant and equipment
-7,721
-7,639
-17,168
-6,951
-449.962
-
Acquisitions, net
-
-
-
-
-
0
Purchases of investments
-808.996
-1,083
-1,142
0
-
-28.364
Sales/maturities of investments
1,246
577.137
1,161
0
807.447
-
Net cash used for investing activities
-7,284
-8,145
-15,280
-6,951
357.485
-
Cash flows from financing activities
Debt repayment
-1,867
-2,156
-7,347
-4,100
-3,100
-
Common stock repurchased
-726.211
-799.036
-1,820
-249.377
0
-
Dividends paid
-
0
-7,673
0
-
-
Other financing activities
-
-67.5
-196.501
-
-1,945
-45
Net cash used provided by (used for) financing activities
-761.085
-2,073
147.862
-3,073
-5,004
-
Net change in cash
-1,126
-1,298
-6,559
-2,098
3,820
-
Cash at beginning of period
1,373
1,704
8,263
10,361
6,541
-
Cash at end of period
247.112
406.067
1,704
8,263
10,361
-
Free cash flow
Operating cash flow
6,919
8,920
8,573
7,926
8,467
-
Capital expenditure
-7,721
-7,639
-17,168
-6,951
-449.962
-
Free cash flow
-802.127
1,281
-8,596
974.923
8,017
-
© 2024 Yahoo. All rights reserved.